MVIR:STO
Medivir AB
SEK 1.44
arrow_downward
-0.83%(-0.012) 1D
Oct 19, 5:29:31 PM GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
SEK 1.45
High
SEK 1.45
Low
SEK 1.42
Mkt. cap
897.57M
Avg. vol.
1.48M
Volume
658.61K
52-wk high
SEK 2.89
52-wk low
SEK 0.34
EPS
-SEK 0.37
Shares outstanding
624.18M
No. of employees
6
Open
SEK 1.45
High
SEK 1.45
Low
SEK 1.42
Mkt. cap
897.57M
Avg. vol.
1.48M
Volume
658.61K
52-wk high
SEK 2.89
52-wk low
SEK 0.34
EPS
-SEK 0.37
Shares outstanding
624.18M
No. of employees
6
News stories
From web sources and news partners
FXStreet
·
1 hour ago
The S&P 500 is on a dangerous path
bloomingbit
·
34 minutes ago
U.S. Stocks Turn Higher; Nasdaq Up 1.36%
www.marketscreener.com
·
1 hour ago
FactSet Research : Are “Magnificent 7” Companies Still Top Contributors to S&P 500 Earnings Growth for Q3
TradingView
·
3 hours ago
The Dow Jones Index Opens 0.08% Lower
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB